What is a myocardial infarction
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding Myocardial Infarction: Definition, Pathophysiology, and Clinical Implications
Definition of Myocardial Infarction
Myocardial infarction (MI), commonly known as a heart attack, is defined by the sudden ischemic death of myocardial tissue. This condition is typically caused by the thrombotic occlusion of a coronary vessel due to the rupture of a vulnerable plaque. Clinically, MI is characterized by the detection of myocardial injury through abnormal cardiac biomarkers, particularly cardiac troponins, in the context of acute myocardial ischemia. The universal definition of MI includes a rise and/or fall of cardiac biomarker values, with at least one value above the 99th percentile of the upper reference limit, along with evidence of acute ischemia such as symptoms, ECG changes, or imaging evidence of new myocardial damage .
Pathophysiology of Myocardial Infarction
The pathophysiology of MI involves several key processes:
- Ischemia and Metabolic Disturbances: Ischemia induces significant metabolic and ionic disturbances in the affected myocardium, leading to rapid depression of systolic function.
- Cardiomyocyte Death: Prolonged ischemia triggers a "wavefront" of cardiomyocyte death, starting from the subendocardium and extending to the subepicardium. This process involves mitochondrial alterations that contribute to both apoptosis and necrosis of cardiomyocytes.
- Inflammatory Response and Healing: The infarcted myocardium heals through scar formation, driven by an inflammatory cascade initiated by alarmins released from dying cells. This process involves the clearance of dead cells and matrix debris by phagocytes, followed by the activation of anti-inflammatory pathways and the conversion of fibroblasts into myofibroblasts, which deposit extracellular matrix proteins.
- Chamber Remodeling: Infarct healing is associated with geometric remodeling of the heart chamber, characterized by dilation, hypertrophy of viable segments, and progressive dysfunction.
Clinical Presentation and Diagnosis
MI can present in various clinical forms, ranging from minor events that may go undetected to major catastrophic events leading to sudden death or severe hemodynamic deterioration. The clinical diagnosis of MI involves the recognition of ischemic symptoms, new significant ECG changes, the appearance of pathological Q waves, and imaging evidence of new loss of viable myocardium or regional wall motion abnormalities .
Epidemiology and Public Health Implications
MI is a major cause of death and disability worldwide, and its incidence serves as a proxy for the prevalence of coronary artery disease in a population. The assessment of MI incidence and case fatality rates is crucial for understanding the burden of cardiovascular disease and for evaluating the effectiveness of public health interventions.
Special Considerations: MINOCA
A subset of MI cases, known as Myocardial Infarction with No Obstructive Coronary Atherosclerosis (MINOCA), accounts for 5-25% of all MIs. MINOCA is characterized by evidence of spontaneous acute MI without significant coronary artery stenosis. The prognosis of MINOCA varies widely depending on its underlying causes, which necessitates a comprehensive diagnostic approach to determine the specific etiology and appropriate treatment .
Conclusion
Myocardial infarction is a complex and multifaceted condition with significant clinical, epidemiological, and public health implications. Understanding its pathophysiology, clinical presentation, and diagnostic criteria is essential for effective management and treatment. Advances in diagnostic tools and biomarkers have enhanced our ability to detect and treat MI, ultimately improving patient outcomes.
Sources and full results
Most relevant research papers on this topic